Patents Assigned to EIi Lilly and Company
  • KCNQ POTENTIATORS
    Publication number: 20240076269
    Abstract: Small molecule potentiatiors to potassium channels (such as Kv7 potentiators—which are also called KCNQ potentiators), compositions including such compounds, and methods of using such compounds for the treatment of Amyotrophic Lateral Sclerosis and other neurological diseases caused by changes in motor neuron excitability, including, but not limited to, primary lateral sclerosis, pseudobulbar palsy, progressive bulbar palsy, progressive muscular atrophy and epilepsy.
    Type: Application
    Filed: November 9, 2023
    Publication date: March 7, 2024
    Applicant: EIi Lilly and Company
    Inventors: Helen Jane Szekeres, Maria Ann Whatton, Andrew Caerwyn Williams